CSM-101

N/A

Report date: 2025/06/06 16:50:21
NME

Base Information

Drug NameCSM-101
Drug Alias NameCSM-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransient receptor potential channel mucolipin 1 agonists
TargetsTransient receptor potential channel mucolipin 1
Therapy Area/IndicationsGaucher DiseaseParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCasma Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCasma Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsGaucher DiseaseParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A